Skip to content
Search AI Powered

Latest Stories

Integrated healthcare system could enable pharmacists to provide effective, efficient patient care: PDA

The lessons from Covid crisis applied in the future through collaboration can create a better integration between GP practices, hospitals and community pharmacies, Pharmacists Defence Association (PDA) has proposed.

Stating that a more integrated healthcare system could enable pharmacists to provide effective and more efficient care to patients, the PDA proposed a model where at least two pharmacists would be working in each community pharmacy, empowered, and enabled with two-way referral pathways, having more clinical input and full access to patient records.


“Such an environment could not only help to improve communications between health professionals and increase access to services for patients, but would support the NHS to operate more effectively.”

While the report by the PDA published last week (Aug 12) requires a rethink of the contribution of community pharmacy, it believes the objectives outlined in the proposals could be achieved with right political will and support from across the sector.

The association believes that the Covid-19 pandemic not only highlighted some of the inefficiencies in the current system but also displayed the level of flexibility that can be adopted when needed.

The report from the PDA illustrates how to achieve this potential.

“With some changes having already occurred, such as the greater use of technology for virtual consultations, it is important to build upon the pandemic experience and embrace a more integrated and collaborative approach to providing health and social care.”

The report has been developed through the combined views and feedback of PDA members. Lord Philip Hunt of Kings Heath, a House of Lords health spokesperson and former minister of state at the Department of Health and Social Care was able to attend a recent meeting of external stakeholders at the House of Lords which discussed the report’s proposals and has written the foreword to the report.

Alison Jones, PDA director of policy said: “The PDA recognises that more than ever before, the NHS needs to adapt and innovate and be integrated with social care. We know that health and social care must move forward and provide high-quality care and address public health issues before they become endemic.

"We also recognise that with the right funding and structures pharmacists based in a variety of settings, including those in local communities, are best placed to carry out many functions and that is what these latest proposals set out to address.”

The report shows how, because of their expertise and accessible positioning, pharmacists can assist with the delivery of the diagnostic programme, and how they can deliver pharmaceutical care to patients previously diagnosed with long term conditions.

The proposals not only create far greater capacity in other parts of the health system, but they dramatically improve the patient's journey.

“This level of collaboration will not happen organically; the joined-up care being advocated can only be delivered through a Community of Practice which is supported by a locally managed system. Members of the healthcare team have been working hard and the system is nearing breaking point. The breaking down of the historical silo approach to healthcare commissioning with a focus upon collaboration will enable the NHS to work smarter for the benefit of the NHS, the workforce and ultimately to the patients that we serve,” said PDA in its report.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less